{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-051511","form_type":"8-K","ticker":"COCH","cik":"0001840877","company_name":"Envoy Medical, Inc.","filed_at":"2024-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.671621+00:00","generated_at":"2026-06-01T05:07:23.672732+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Envoy Medical: Dr. Haring-Smith resigns from board; Michael Crowe appointed","bullets":["Dr. Whitney Haring-Smith resigned effective June 6, 2024; no disagreement.","Board appointed Michael Crowe on June 7, 2024 to fill vacancy.","Crowe receives $40k annual cash and 25,000-share option award vesting over 4 years.","Crowe is SVP Operations at Bioventus, former VP Operations at Abbott Vascular.","Envoy expects to begin pivotal clinical study for Acclaim CI later in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-051511","json":"https://secwatch.observer/filing/0001213900-24-051511.json","markdown":"https://secwatch.observer/filing/0001213900-24-051511.md","text":"https://secwatch.observer/filing/0001213900-24-051511.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840877/000121390024051511/0001213900-24-051511-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840877/000121390024051511/ea0207623-8k_envoy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:07:23.672732+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3c8488a81b","claim":"Michael Crowe was appointed as Director at Envoy Medical, Inc..","evidence_excerpt":"On June 7, 2024, the Board appointed Michael Crowe to fill the vacancy created by Dr. Haring-Smith’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000121390024051511/0001213900-24-051511-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"60ae2d53de","claim":"Whitney Haring-Smith resigned as Director at Envoy Medical, Inc..","evidence_excerpt":"On June 6, 2024, Dr. Whitney Haring-Smith, notified the Company of his decision to resign from the board of directors of the Company (the “Board”) effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000121390024051511/0001213900-24-051511-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}